Aspergillus spp. have been shown to induce T-helper cell (Th) 1 and Th17 subsets resulting in elevated levels of several cytokines. The objective of this study was to analyse a bundle of cytokines in serum and bronchoalveolar lavage fluid (BALF) in patients with and without invasive pulmonary aspergillosis (IPA). This nested case-control analysis included 10 patients with probable/proven IPA and 20 matched controls without evidence of IPA, out of a pool of prospectively enrolled (2014-2017) adult cases with underlying haematological malignancies and suspected pulmonary infection. Serum samples were collected within 24 hours of BALF sampling. All samples were stored at −70°C for retrospective determination of cytokines. IL-6 and IL-8 were significantly associated with IPA in both serum (P = .011 and P = .028) and BALF (P = .006 and P = .012, respectively), and a trend was observed for serum IL-10 (P = .059). In multivariate conditional logistic regression analysis, IL-10 remained a significant predictor of IPA in serum and IL-8 among BALF cytokines. In conclusion, levels of IL-6 and IL-8 were significantly associated with probable/proven IPA, and a similar trend was observed for serum IL-10. Future cohort studies should determine the diagnostic potential of these cytokines for IPA, and evaluate combinations with other IPA biomarkers/diagnostic tests.
| INTRODUCTION
Invasive pulmonary aspergillosis (IPA) is associated with high morbidity and mortality among patients with underlying haematological malignancies. 1, 2 Due to the crude mortality of 80%-90% in the absence of adequate treatment, timely diagnosis and early start of antifungal therapy are key factors in the successful treatment of IPA. 3, 4 The introduction of non-cultural diagnostic tests for IPA in blood and bronchoalveolar lavage fluid (BALF), including galactomannan antigen (GM)
testing, 5, 6 PCR, 7, 8 the Aspergillus-specific lateral flow device test [9] [10] [11] [12] and 1,3-β-d-glucan (BDG) testing, 13 was associated with a significant increase in the rate of IPA-diagnosed premortem (vs postmortem).
14 Despite these significant advancements, performance of these noncultural diagnostic tests is varying, and the search for a reliable gold standard for diagnosis of IPA premortem continues.
Performance of currently available biomarkers may be enhanced by combination with sensitive and specific immunological markers. In fact, Aspergillus spp. have been shown to induce T-helper cell (Th) 1
and Th17 subsets resulting in elevated levels of several cytokines. 15, 16 However, diagnostic potential of these immunological markers for diagnosis of IPA in a clinical setting has not been evaluated yet. The objective of this nested case-control analysis of a prospective cohort study was to analyse a bundle of cytokines in serum and BALF in adult patients with underlying haematological malignancies with and without IPA.
| MATERIALS AND METHODS
This nested case-control study of prospectively collected data comprised paired routine serum and BALF samples obtained on the same day from 10 cases with IPA and 20 matched controls without IPA.
In total, 106 patients with haematological malignancies undergoing bronchoscopy were prospectively enrolled at the Medical University presented including 95% CI, for cytokine levels using two approaches:
(i) including extrapolated levels if below the standard range, and (ii) levels below the standard range set to 0. Optimal cut-offs for discriminating patients with and without IPA were calculated by using the Youdens index. Utilising Cox survival analysis in SPSS, conditional logistic regression models were calculated for matched case-control pairs utilising these optimal cut-offs and adjusted for covariates used for matching, and hazard ratios (HR) including 95% CI were displayed.
The sample size of 30 (with 10 cases and 20 controls) gave us 80%
power (α = .05) to detect a HR of 3.0 or above. Two-sided P<.05 was taken as cut-off for statistical significance.
| RESULTS
A total of 30 patients were included in the final analysis. characteristics are displayed in Table 1 .
For all patients corresponding concurrent BALF and serum samples were collected within a time frame of <24 hours. Median, IQR, minimum and maximum cytokine levels in cases and controls are depicted in Table 2 . Box plots for IL-6, IL-8, and IL-10 in serum are depicted in Figure 1 , box plots for IL-6 and IL-8 in BALF are depicted in Figure 2 .
AUCs for serum cytokines for differentiating between cases and controls with and without extrapolated levels are depicted in Table 3 .
When including extrapolated levels IL-6, IL-8, IL-10 and IL-17A were all significantly associated with IPA with AUCs between 0.73 and 0.81.
After removing extrapolated levels below the standard range, however, only IL-6 and IL-8 were significantly associated with IPA and a trend was observed for IL-10 (P = .059). AUCs for BALF cytokines are also depicted in Table 3 . Both IL-6 and IL-8 were significantly associated with IPA with AUCs of 0.810 and 0.785, respectively. ROC curves for IL-6, IL-8 and IL-10 in serum are displayed in Figure 3A , ROC curves for IL-6 and IL-8 in BALF are displayed in Figure 3B .
Cut-offs calculated for serum by using Youdens index as well as results of univariate conditional logistic regression analysis for predicting the event of IPA are depicted in 
(A) (B)
HR: 11.685, 95% CI: 1.423-95.915; P = .022) remained significant, while IL-6 as well as covariates used for matching were not significant.
Among patients with probable/proven IPA, 7 out of 10 had received mould active antifungals for more than 2 days before BALF and blood samples were obtained (median: 25 days, range: 8 to >360 days).
Serum levels of IL-2R (P = .033) and IL-22 (P = .017) were significantly lower in those receiving antifungals >2 days, and trends towards lower levels were also observed for IL-8, IL-10 and IL-17A. In sub-analysis of only those three patients with probable/proven IPA who had received mould active antifungals for ≤2 days before sampling and their respective matched controls, serum IL-6, IL-8, IL-22 and RANTES were significantly higher in patients with IPA, while trends were also observed for IL-10 and IL-2R. In BALF, only IL-17A levels were significantly lower in those receiving antifungals >2 days versus those IPA cases without antifungals, with similar trends observed for IL-6 and IL-2R (all analyses after removal of extrapolated levels).
| DISCUSSION
In this nested case-control study, we investigated the diagnostic performance of a bundle of cytokines in serum and BALF for diagnosing IPA among patients with underlying haematological malignancies.
We found that serum and BALF concentrations of IL-6 and IL-8 were significantly higher in patients with probable/proven IPA compared to those without evidence of IPA. We also found a trend towards el- -naive T cells into Th2 and Th17 cells, 15, 37 thereby influencing the Th1/Th2 balance which is known to be a critical factor determining the outcome of invasive fungal infections. 38 The mechanism of IL-6 and IL-8 increase during IPA has been stud- 1.000
Significant differences (P < .05) are in bold. AUC, area under the curve; CI, confidence interval the lectin pathway, potentiate IL-8 secretion of A549 lung epithelial cells. 42 A similar mechanism has also been proposed for infections caused by Aspergillus flavus. 43 After in vitro stimulation with A. fumigatus, Kruppel-like Factor 4 has been shown to modulate IL-6 release in human dendritic cells. 37 Dectin-1-dependent IL-6 production regulates expression of iron chelators, haem and siderophore-binding proteins and hepcidin in infected mice and reduces systemic iron levels. 16, 33, 44 A pivotal role for IL-6 in protective immunity against Aspergillus has been reported in mice. 35 While IL-6 also plays a role in the transition from innate to acquired immunity during bacterial infection, 45 IL-6 may be predominantly elevated in IPA vs other infections of the lung, in-
cluding Pneumocystis carinii pneumonia.
46
We also found a trend towards increased serum levels of IL-10 in patients with probable/proven IPA and in serum IL-10 was the major predictor of IPA in multivariate conditional logistic regression analysis.
IL-10 is an immunosuppressive cytokine and a central negative regulator of inflammatory responses, which has been attributed a largely detrimental role during fungal disease. 16, 18, 29, 47 In a study by Potenza and colleagues, Aspergillus-specific T-cells producing non-protective IL-10 and protective IFN-γ were exclusively detected in haematologic malignancy patients with invasive aspergillosis and not in uninfected controls. 30 In contrast to findings of Potenza's study, we did not find an increase of IFN-γ levels in patients with IPA. We could also not verify findings by Ceesay and colleagues who reported that baseline IL-15, IL-2R, CCL2 and MIP-1α were significantly higher, while IL-4 was lower in patients with proven/probable invasive fungal infection compared to those with no evidence of fungal infection. 34 The latter study included a variety of fungal diseases, including yeast infections with very different immunological characteristics, 48 which may explain the difference to our nested case-control study which focused exclusively on IPA.
IL-17A levels found in this study were very low in patients and controls, and once we excluded levels that were extrapolated below the standard range, not significantly different between cases and controls. F I G U R E 3 Receiver operating characteristics (ROC) curve analysis of IL-6, IL-8 and IL-10 in serum and IL-6 and IL-8 in bronchoalveolar lavage fluid (BALF) for diagnosing probable/proven invasive pulmonary aspergillosis a poor inducer of IL-17. 49 As an important limitation our nested casematched control study design, which generally provides a better evidence level than a classic case-control study, 50 does not allow us to draw any conclusions regarding the added benefit of cytokine testing in addition to, for example, GM testing or PCR. Future larger cohort studies are needed to determine whether the diagnostic potential of IL-6, IL-8 and IL-10, without taking into account multiple covariates that may also result in higher cytokine levels, holds value for clinical routine. Also controls included in this study had suspected pulmonary infection for which they were undergoing routine bronchoscopy and microbiological workup of BALF samples. Other pulmonary infections may have caused increased levels of certain cytokines in controls explaining findings of this study that differ from previous studies which used uninfected controls. Cytokine levels may also vary according to underlying diseases and conditions for which our conditional analysis accounted for, however, larger studies are needed to evaluate whether cytokine levels can only be interpreted when taking into account these conditions. Finally, our study, although severely underpowered for subanalysis, showed some trends towards cytokines having less discriminatory power among those with ongoing mould-active antifungals.
Future larger studies are also needed to evaluate this observation.
In conclusion, levels of IL-6 and IL-8 were significantly higher in patients with probable/proven IPA compared to controls without evidence of IPA. A trend was also observed for serum IL-10 levels. Future cohort studies should determine the diagnostic potential of these cytokines for IPA, and evaluate combinations of these cytokines with other IPA biomarkers/diagnostic tests, such as GM and PCR.
